Dr Reddys Laboratories (RDY) Revenue Growth (3y) (2012 - 2023)
Dr Reddys Laboratories (RDY) Revenue Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.22% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 4.22% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.31% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1.40% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 28.43% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.98% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | -7.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 7.26% |
| Mar 31, 2023 | 10.51% |
| Sep 30, 2022 | 10,930.27% |
| Jun 30, 2021 | 14.03% |
| Mar 31, 2021 | 8.93% |
| Sep 30, 2020 | 4.89% |
| Sep 30, 2019 | 1.68% |
| Mar 31, 2019 | -0.78% |
| Dec 31, 2018 | -0.17% |
| Sep 30, 2018 | -2.39% |
| Jun 30, 2018 | -4.89% |
| Dec 31, 2017 | -5.99% |
| Sep 30, 2017 | -1.39% |
| Dec 31, 2016 | -0.06% |
| Sep 30, 2016 | 0.75% |
| Mar 31, 2016 | 26.43% |
| Dec 31, 2015 | -1.60% |
| Sep 30, 2015 | 4.69% |
| Jun 30, 2015 | -71.17% |
| Dec 31, 2014 | -71.41% |